- Home
- FTV vs WST Comparison
FTV vs WST Comparison
Compare FTV & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTV | WST |
|---|---|---|
| Founded | 2015 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7B | 20.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FTV | WST |
|---|---|---|
| Price | $55.64 | $277.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | $56.64 | ★ $346.78 |
| AVG Volume (30 Days) | ★ 3.0M | 715.4K |
| Earning Date | 02-06-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.43% | 0.32% |
| EPS Growth | N/A | ★ 0.17 |
| EPS | 1.75 | ★ 6.75 |
| Revenue | ★ $6,260,300,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $7.01 |
| Revenue Next Year | $3.02 | $6.20 |
| P/E Ratio | ★ $31.74 | $41.10 |
| Revenue Growth | ★ 36.34 | 4.92 |
| 52 Week Low | $46.34 | $187.43 |
| 52 Week High | $83.32 | $348.90 |
Technical Indicators
Market Signals| Indicator | FTV | WST |
|---|---|---|
| Relative Strength Index (RSI) | 64.79 | 55.00 |
| Support Level | $54.44 | $264.92 |
| Resistance Level | $55.91 | $278.43 |
| Average True Range (ATR) | 0.89 | 6.66 |
| MACD | -0.01 | 0.70 |
| Stochastic Oscillator | 89.09 | 69.07 |
Price Performance
Historical ComparisonAbout FTV Fortive Corporation
Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.2 billion in revenue in 2024.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.